News and Trends 8 Oct 2025 Top biotech deals in September 2025 Discover the top biotech deals of September 2025, as four billion-dollar acquisitions took place and several licensing deals were signed. October 8, 2025 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 7 Oct 2025 Six companies leading the mRNA revolution in biotechnology Here are six mRNA biotechs that have raised funds in recent years to push their candidates ahead through preclinical and clinical trials. October 7, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 1 Oct 2025 Merck backs out of Britain: is the U.K. struggling to retain its life sciences sector? Merck’s decision to back out of its $1 billion expansion comes as U.K. investments in life sciences declines. October 1, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 29 Sep 2025 First-ever approval for Barth Syndrome treatment: what does this mean for ultra-rare disease therapeutics? FDA approval for Stealth BioTherapeutics’ elamipretide has been a long time coming. What does this mean for other ultra-rare disease companies? September 29, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 24 Sep 2025 Resurrecting the dodo: an ethical dilemma or chance at restoring biodiversity? Colossal Biosciences has just had a major breakthrough in its attempt to revive the dodo bird. What are the ethical concerns? September 24, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 22 Sep 2025 Paper mills are a network: scientific fraud growing rapidly A new study has uncovered a network of paper mills contributing towards scientific fraud and disinformation. September 22, 2025 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 19 Sep 2025 GLP-1 drugs on WHO Essential Medicines List: what’s the impact? The WHO has added GLP-1 agonists to its Essential Medicines List in 2025. Learn more about the impact of this decision. September 19, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 17 Sep 2025 Budget blues: where are cell and gene therapies heading? The European Cell & Gene Therapy Summit 2025 was a hotspot for scientists and investors to discuss critical issues faced by the industry. September 17, 2025 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 10 Sep 2025 Kriya Therapeutics has raised over $1.2 billion, but for what? Gene therapies have witnessed a decline in investor interest in recent times. Despite this, Kriya Therapeutics seems to be attracting funds in the space. September 10, 2025 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 9 Sep 2025 Top biotech deals in August 2025 Discover the top biotech deals of August 2025, as several big pharmas shopped around, especially in the field of small molecules. September 9, 2025 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 5 Sep 2025 Closing treatment gaps in yellow fever: are germ-free egg-based vaccines the answer? Germ-free egg-based vaccines could be the answer to curbing yellow fever outbreaks. September 5, 2025 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 3 Sep 2025 How are biotechs tackling malaria? As a recent approval closes a major therapeutic gap, let’s take a look at some of the latest progress and new treatments against malaria. September 3, 2025 - 13 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email